Results 201 to 210 of about 30,114 (242)
Some of the next articles are maybe not open access.
Pathogenesis of ANCA-Associated Vasculitis
Current Rheumatology Reports, 2012Antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitides (AAV) are a group of systemic vasculitis syndromes characterized by inflammation and necrosis of blood vessel walls. Genetic, epigenetic, and environmental factors contribute to the etiology and pathogenesis of AAV.
Rodrigo, Cartin-Ceba +2 more
openaire +2 more sources
2009
The majority of patients with Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) have antineu-trophil cytoplasmic antibodies (ANCA) in their serum. This is particularly true of patients with "disseminated" disease, the great majority of whom are ANCA positive.
Stone, John H. +7 more
openaire +2 more sources
The majority of patients with Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) have antineu-trophil cytoplasmic antibodies (ANCA) in their serum. This is particularly true of patients with "disseminated" disease, the great majority of whom are ANCA positive.
Stone, John H. +7 more
openaire +2 more sources
Treatment of ANCA-associated vasculitis
Nature Reviews Nephrology, 2013Antineutrophil cytoplasmic autoantibody (ANCA)-associated diseases are small-vessel vasculitides, encompassing granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
Ulf, Schönermarck +2 more
openaire +2 more sources
Advances in Kidney Disease and Health
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts.
Purva Sharma, Reza Zonozi, Duvuru Geetha
openaire +2 more sources
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts.
Purva Sharma, Reza Zonozi, Duvuru Geetha
openaire +2 more sources
Epidemiology of ANCA-associated Vasculitis
Rheumatic Disease Clinics of North America, 2010The epidemiology of the antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), comprising Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome, poses considerable challenges to epidemiologists. These challenges include the difficulty of defining a case with a lack of clear distinction between the different ...
Ntatsaki, Eleana +2 more
openaire +3 more sources
Novel Therapies for ANCA-associated Vasculitis
Current Rheumatology Reports, 2021The purpose of this review is to discuss the most recent evidence on the treatment innovations and future prospective in the management of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs).In AAV, a growing body of research is available on novel treatment options for remission induction and to clarify some uncertainties ...
Monti S. +5 more
openaire +5 more sources
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2002
ANCA-associated vasculitis. The term "antineutrophil cytoplasm antibody (ANCA)- associated vasculitis" (AASV) ihighers generally used to include primary vasculitis syndromes in which circulating ANCA against proteinase 3 (PR3) and myeloperoxidase (MPO) are commonly found.
SINICO, RENATO ALBERTO +3 more
openaire +2 more sources
ANCA-associated vasculitis. The term "antineutrophil cytoplasm antibody (ANCA)- associated vasculitis" (AASV) ihighers generally used to include primary vasculitis syndromes in which circulating ANCA against proteinase 3 (PR3) and myeloperoxidase (MPO) are commonly found.
SINICO, RENATO ALBERTO +3 more
openaire +2 more sources
Treatment of ANCA-Associated Vasculitis
New England Journal of Medicine, 2003Vasculitis is defined by inflammation of the blood-vessel wall and forms the pathological foundation of a diverse group of individual disease entities. Among the primary systemic vasculitic diseases, Wegener's granulomatosis and microscopic polyangiitis share several common features, including pulmonary capillaritis, pauci-immune focal crescentic ...
openaire +2 more sources
Classification of ANCA-Associated Vasculitis
Current Rheumatology Reports, 2013Classification of the ANCA-associated vasculitides remains controversial. Existing systems, developed by the American College of Rheumatology (ACR) in 1990, the Chapel Hill Consensus Conference (CHCC) in 1994 and updated in 2012, and the European Medicines Agency algorithm, all have deficiencies, especially when applied to unselected patients.
Irfan, Khan, Richard A, Watts
openaire +2 more sources
The Future of ANCA-associated Vasculitis
Rheumatic Disease Clinics of North America, 2010The introduction of cyclophosphamide for treatment and the detection of antineutrophil cytoplasmatic antibodies (ANCA) as a seromarker for ANCA-associated vasculitis (AAV) have been the most important milestones in the history of AAV. Nevertheless, there are still many issues to resolve to fully understand the pathogenesis of AAV and to improve patient
Julia U, Holle +2 more
openaire +2 more sources